FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1143011000001105: Quinine bisulphate 300mg tablets 500 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21949701000001113 Quinine bisulphate 300mg tablets 500 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
75149901000001119 Quinine bisulfate 300mg tablets 500 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

7 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Quinine bisulphate 300mg tablets 500 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet Is pack of Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet Has active ingredient Quinine bisulfate false Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet Has VMP Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet Has specific active ingredient Quinine bisulfate true Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets 500 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Quinine bisulfate 300mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is a True Quinine bisulphate 300mg tablets 500 tablet Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets (A A H Pharmaceuticals Ltd) 500 tablet Is a True Quinine bisulphate 300mg tablets 500 tablet Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets (Unichem Plc) 500 tablet Is a True Quinine bisulphate 300mg tablets 500 tablet Inferred relationship Existential restriction modifier
Quinine bisulfate 300mg tablets (Viatris UK Healthcare Ltd) 500 tablet Is a True Quinine bisulphate 300mg tablets 500 tablet Inferred relationship Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd) 500 tablet Is a True Quinine bisulphate 300mg tablets 500 tablet Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets (Arrow Generics Ltd) 500 tablet Is a True Quinine bisulphate 300mg tablets 500 tablet Inferred relationship Existential restriction modifier
Quinine bisulphate 300mg tablets (Dowelhurst Ltd) 500 tablet Is a True Quinine bisulphate 300mg tablets 500 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start